-transparent.png){kind=logo}
A single-blind, between-patients trial was run to compare the fluidifying, expectorant, antitussive, antipyretic and anti-inflammatory activity, and the local and systemic tolerance of guacetisal, an active principle obtained by the esterification of acetylsalicylic acid and guaiacol, and oxolamine phosphate, in which the suspension formulation for adults was administered to 30 presenile and senile patients of both sexes with chronic obstructive bronchopathy. A higher activity on the part of guacetisal was noted. The results obtained are illustrated and discussed.
Related Publications
R Cerqua, and
C Trovello, and
G Infante, and
S Ricciardi
February 1981,
Minerva medica,
R Cerqua, and
C Trovello, and
G Infante, and
S Ricciardi
February 1981,
Minerva medica,
R Cerqua, and
C Trovello, and
G Infante, and
S Ricciardi
February 1981,
Minerva medica,
R Cerqua, and
C Trovello, and
G Infante, and
S Ricciardi
February 1981,
Minerva medica,
R Cerqua, and
C Trovello, and
G Infante, and
S Ricciardi
April 1993,
Revue medicale de Bruxelles,
R Cerqua, and
C Trovello, and
G Infante, and
S Ricciardi
October 1981,
La Clinica terapeutica,
R Cerqua, and
C Trovello, and
G Infante, and
S Ricciardi
April 1983,
La Clinica terapeutica,
R Cerqua, and
C Trovello, and
G Infante, and
S Ricciardi
November 1991,
Schweizerische medizinische Wochenschrift,
R Cerqua, and
C Trovello, and
G Infante, and
S Ricciardi
January 1981,
Archivio Monaldi per la tisiologia e le malattie dell'apparato respiratorio,
R Cerqua, and
C Trovello, and
G Infante, and
S Ricciardi
November 1966,
Giornale di clinica medica,
